Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Sep 25, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how red blood cell transfusions affect the heart's function in older patients who are anemic, which means they have low levels of red blood cells. The researchers want to see if there are any changes in heart measurements taken using a test called echocardiography before, immediately after, and 15 minutes after the transfusion. They hope to find out which heart measurement is most affected by the transfusion.
To be eligible for this trial, participants need to be older adults who require a red blood cell transfusion and can give their consent to join the study. They should not have received more than 500 mL of fluid through an IV in the last hour, as this could affect the results. If you or a loved one are considering participating, you can expect a simple heart test that will help doctors understand how blood transfusions might improve heart function in anemic patients. This study aims to provide important information that could benefit future patients in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patient needing red blood cell transfusion
- • consent
- • social protection
- Exclusion Criteria:
- • fluid filing over 500 mL of crystalloids
- • transfusion in the last hour
About Centre Hospitalier Universitaire De Nīmes
The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nîmes, Gard, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported